Return to Play/Coach Criteria for YOUTH LACROSSE COACHES or PLAYERS
with Suspected or Confirmed COVID-19 or who have potential exposure to a family
member with Confirmed COVID-19
Symptomatic YOUTH LACROSSE COACHES or PLAYERS with suspected or confirmed
COVID-19 (Either strategy is acceptable)
Per California Department of Public Health :
Children and teens with symptoms of COVID-19 should not attend practices or
competition. They should consult their physician for testing and notify their coach of their symptoms.
Youth recovering from COVID-19 will have different paths to return to sports based
on the severity of their illness. Those who are asymptomatic or have mild symptoms
should not exercise until cleared by a physician. See the American Academy of
Pediatrics Interim Guidance on Return to Sports for additional guidance of more
Symptom-based strategy. Exclude from participation until At least 3 days (72 hours) have passed since recovery defined as resolution of fever without the use of fever-reducing medications and improvement in
respiratory symptoms (e.g., cough, shortness of breath); and, At least 10 days have passed since symptoms first appeared
Test-based strategy. Exclude from participation until Resolution of fever without the use of fever-reducing medications and Improvement in respiratory symptoms (e.g., cough, shortness of breath), and Negative results of an FDA Emergency Use Authorized COVID-19 molecular assay for detection of SARS-CoV-2 RNA from at least two consecutive respiratory specimens collected ≥24 hours apart (total of two negative specimens)  See Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for 2019 Novel Coronavirus (2019-nCoV ). Of note, there have been reports of prolonged detection of RNA without direct correlation
to viral culture.
YOUTH LACROSSE COACHES or PLAYERS with laboratory-confirmed COVID-19 who
have not had any symptoms (Either strategy is acceptable)
Time-based strategy. Exclude from participation until: 10 days have passed since the date of their first positive COVID-19 diagnostic test assuming they have not subsequently developed symptoms since their positive test. If they develop symptoms, then the symptom-based or test-based strategy should be used. Note, because symptoms cannot be used to gauge where these individuals are in the course of their illness, it is possible that the duration of viral shedding could be longer or shorter than 10 days after their first positive test.
Test-based strategy . Exclude from participation until: Negative results of an FDA Emergency Use Authorized COVID-19 molecular assay for detection of SARS-CoV-2 RNA from at least two consecutive respiratory specimens collected ≥24 hours apart (total of two negative specimens). Note, because of the absence of symptoms, it is not possible to gauge where these individuals are in the course of their illness. There have been reports of prolonged detection of RNA without direct correlation to viral culture.
Note that detecting viral RNA via PCR does not necessarily mean that infectious virus is
YOUTH LACROSSE COACHES or PLAYERS who have been exposed to a confirmed case
within their immediate family, household or team should:
Quarantine for 14 days once the COVID-19 exposure is reported as long as
the exposed individual has no symptoms
If YOUTH LACROSSE COACHES or PLAYERS had COVID-19 ruled out and have an alternate
diagnosis (e.g., tested positive for influenza), criteria for return to work should be based
on that diagnosis.
Return to Work Practices and Work Restrictions
After returning to participate, YOUTH LACROSSE COACHES or PLAYERS should: Wear a facemask for source control at all times while in the Field facilities until all symptoms are completely resolved or at baseline. A facemask instead of a cloth face covering should be used by these YOUTH LACROSSE COACHES OR PLAYERS for source control during this time period while in the facility.
A facemask for source control does not replace the need to wear an N95 or higher-level respirator (or other recommended PPE) when indicated, including when caring for patients with suspected or confirmed COVID-19.
Of note, N95 or other respirators with an exhaust valve might not provide source control.
Self-monitor for symptoms, and seek re-evaluation from occupational health if respiratory symptoms recur or worsen.
1 All test results should be final before isolation is ended. Testing guidance is based upon
limited information and is subject to change as more information becomes available. In
persons with a persistent productive cough, SARS-CoV-2-RNA might be detected for
longer periods in sputum specimens than in upper respiratory tract specimens.
Cloth face covering: Textile (cloth) covers are intended to keep the person wearing one
from spreading respiratory secretions when talking, sneezing, or coughing. They are not
PPE and it is uncertain whether cloth face coverings protect the wearer. CDC has
guidance available on the design, use, and maintenance of cloth face coverings.
Facemask: Facemasks are PPE and are often referred to as surgical masks or procedure
masks. Use facemasks according to product labeling and local, state, and federal
requirements. FDA-cleared surgical masks are designed to protect against splashes and
sprays and are prioritized for use when such exposures are anticipated, including
surgical procedures. Facemasks that are not regulated by FDA, such as some procedure
masks, which are typically used for isolation purposes, may not provide protection
against splashes and sprays.
Respirator: A respirator is a personal protective device that is worn on the face, covers
at least the nose and mouth, and is used to reduce the wearer’s risk of inhaling
hazardous airborne particles (including dust particles and infectious agents), gases, or
vapors. Respirators are certified by the CDC/NIOSH, including those intended for use in